Report Overview

2023

Base Year

2018-2023

Historical Year

2024-2032

Forecast Year

Global Adeno-Associated Virus Vector-Based Gene Therapy Market Share

Market Segmentation Based on Application Areas is Anticipated to Witness Substantial Growth

Based on therapeutic application, the market segmentation includes neurological disorders, ophthalmic disorders, muscular disorders, hematological disorders, and metabolic disorders. The neurological disorders have seen significant growth which can be attributed to an increasing prevalence of neurological diseases like Alzheimer’s and Parkinson’s, where AAV vector show promise in transporting genetic material directly to the brain. With the progress in research and clinical trials, the potential for treating complex diseases is expanding, thereby providing the market with significant growth.

 

For targeting retinal cells, AAV vectors are suitable and makes then ideal in treating inherited retinal diseases. Innovations in vector engineering and delivery techniques are considered to improve safety and efficacy of treatment, propelling significant market growth in the ophthalmic sector.

 

Rare Disease Target is Expected to Lead the Market Share

Based on target disease, the market constitutes rare diseases, cancer, and inherited genetic disorders. Rare disease segment benefits from regulatory support as orphan drug designations that provide benefit like market exclusivity and tax incentives. The emphasis on rare diseases, which often have limited effective treatment options fuels a significant part of research and development in AAV vector gene therapy. With advancements in target and vector optimization the potential to develop curative therapies is high.

 

The use of AAV vector in oncology to transport the tumor suppressor genes or suicide genes into cancer cells is growing. With the rising incidence of cancer worldwide along with limitations of current therapies in terms of side effects and specificity, there is strong investment and research in this domain. As AAV-based therapies for cancer advance through clinical trials and receive approvals, this segment is poised for rapid growth.

 

Adeno-Associated Virus Vector-Based Gene Therapy Market Report Snapshots

Adeno-Associated Virus Vector-Based Gene Therapy Market Size

Adeno-Associated Virus Vector-Based Gene Therapy Market Growth

Adeno-Associated Virus Vector-Based Gene Therapy Market Trends

Adeno-Associated Virus Vector-Based Gene Therapy Market Share

Adeno-Associated Virus Vector-Based Gene Therapy Market Regional Analysis

Adeno-Associated Virus Vector-Based Gene Therapy Companies

 

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Purchase Full Report

Datasheet

 

USD 2,969

USD 2,699

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 5,499

USD 4,999

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 6,599

USD 5,999

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 7,699

USD 6,999

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

Back to top

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


Australia

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63 287899028, +63 967 048 3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124

$getforecastarray = array(); if (isset($ismapshow)) { $forecast_period_start = isset($forecast_period_start) ? $forecast_period_start : ''; if ($forecast_period_start != "") { $yearInc = 1; for ($startfrom = $forecast_period_start; $startfrom <= $forecast_period_end; $startfrom++) { $calculatFercastYear = calculateFutureValue(($getReportDetail['base_value'] > 0) ? $getReportDetail['base_value'] : 100, $getReportDetail['cagr'], $yearInc); $getforecastarray[] = array('years' => "$startfrom", 'value' => $calculatFercastYear); $yearInc++; } } } $getforecastarrayJson = json_encode($getforecastarray); ?>